Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
Study Identifier
M04-690
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18 - 75 Years
Protocol Summary
To evaluate the long-term maintenance of response, safety and tolerability of repeated
administration of adalimumab in subjects with Crohn's disease who participated in and
successfully completed Protocol M02-404 or Protocol M04-691.
Study Locations
Location
Status
Location
Site Ref # / Investigator 1894
Huntsville, Alabama, United States, 35801
Status
Not applicable
Location
Site Ref # / Investigator 1895
Jacksonville, Alabama, United States, 35801
Status
Not applicable
Location
Site Ref # / Investigator 1787
La Jolla, California, United States, 92037
Status
Not applicable
Location
Site Ref # / Investigator 1902
Roseville, California, United States, 95661
Status
Not applicable
Location
Site Ref # / Investigator 1824
San Diego, California, United States, 92123
Status
Not applicable
Location
Site Ref # / Investigator 1891
San Diego, California, United States, 92123
Status
Not applicable
Showing {first} - {last} of {total} Results